topmain

HOTELS IN CHINA AND ASIA

CLICK HERE FOR ONLINE HOTEL RESERVATION

IT IS INTERESTING!

The largest Nasdaq Biotech index decline since 2008 - it could lead down the Nasdaq and S&P PDF Print E-mail
Monday, 28 September 2015 18:53

Over the last week there is the biggest since October 2008, the fall of the index biotechnology and pharmaceutical companies Nasdaq Biotech - nearly 19 percent. Formally, the cause of the fall served tweet Hillary Clinton that she would take the price of pharmaceutical companies under control if elected US president, after the sensational recent history, when Martin Shkreli, founder of the biopharmaceutical company Turing Pharmaceuticals, bought for $ 55 million right medicine Daraprim and raised its price from $ 13.5 to $ 750. Such a drop in the index of Nasdaq Biotech could lead down the Nasdaq and S & P, as earlier stocks of medical companies to justify itself as the best investments and helped the Nasdaq and S & P set new records, now a powerful catalyst Nasdaq and S & P turned off, so the Nasdaq and S & P may start to decline in the near future: